ArticleCancer2009

Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.

George Van Buren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.